tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
Advertisement

Halozyme (HALO) Technical Analysis

Compare
1,109 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 67.61, while Halozyme Therapeutics’s (HALO) share price is $70.13, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 67.99, while Halozyme Therapeutics’s (HALO) share price is $70.13, making it a Buy.

Halozyme (HALO) Pivot Points

Nov 12, 2025, 10:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
66.12
67.05
67.53
68.46
68.94
69.87
70.35
Fibonacci
67.05
67.59
67.92
68.46
69.00
69.33
69.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Nov 12, 2025, 10:15 AM
Period
Simple
Exponential
MA5
68.61Buy
68.60Buy
MA10
67.24Buy
67.83Buy
MA20
66.80Buy
67.61Buy
MA50
70.49Sell
67.99Buy
MA100
65.78Buy
66.10Buy
MA200
62.10Buy
62.03Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 67.83, while Halozyme Therapeutics’s (HALO) share price is $70.13, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 66.10, while Halozyme Therapeutics’s (HALO) share price is $70.13, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $70.13 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 70.49, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $70.13 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 65.78, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $70.13 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 62.10, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Nov 12, 2025, 10:15 AM
Name
Value
Implied Action
RSI (14)
61.39
Neutral
STOCH (9,6)
74.37
Neutral
STOCHRSI (14)
74.37
Neutral
MACD (12,26)
-0.12
Sell
ADX (14)
23.57
Neutral
Williams %R
-5.56
Sell
CCI (14)
151.16
Sell
ATR (14)
2.20
-
Ultimate Oscillator
48.19
Neutral
ROC
6.63
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 61.39, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 23.57, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is 151.16, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 6.63, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Buy.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 61.39, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is -0.12, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 68.61, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 66.80, which suggests HALO is a Buy.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 70.49, which suggests HALO is a Sell.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 62.10, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -5.56, which suggests HALO is a Sell.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is 151.16, which suggests HALO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis